Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00259-002-1085-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multilayered Insights into Poorly Differentiated, -Positive, Thyroid Carcinoma in a Rapidly Developing Goiter with Retrosternal Extension: From En "Y" Cervicotomy to SPECT/CT-Positive Lung Metastases.
Diagnostics (Basel)
August 2025
Department of Clinical Endocrinology V, "C.I. Parhon" National Institute of Endocrinology, 011863 Bucharest, Romania.
Poorly differentiated thyroid malignancy, a rare histological type of aggressive thyroid malignancy with associated difficulties and gaps in its histological and molecular characterization, might lead to challenging clinical presentations that require a prompt multimodal approach. This case study involved a 56-year-old, non-smoking male with a rapidly developing goiter (within 2-3 months) in association with mild, non-specific neck compressive symptoms. His medical history was irrelevant.
View Article and Find Full Text PDFSystemic Therapy for Advanced Thyroid Cancer-New Personalized Options.
Drugs
August 2025
Thyroid Unit, The Royal Marsden NHS Foundation Trust, 203 Fulham Road, London, SW3 6JJ, United Kingdom.
Tyrosine kinase inhibitors (TKIs) have revolutionised systemic therapy for advanced thyroid cancers, including radioiodine-refractory differentiated thyroid cancer (RR-DTC), anaplastic thyroid cancer (ATC) and medullary thyroid cancer (MTC), which respond poorly to conventional cytotoxic chemotherapy. The treatment of advanced thyroid cancer is also increasingly personalised, with recent advances in genomic-driven, highly selective targeted therapies. This review summarises contemporary evidence regarding the efficacy, safety and clinical application of drug therapies in thyroid cancers, whilst exploring their evolving role in the age of personalised medicine.
View Article and Find Full Text PDFPhytoremediation potential for radionuclide removal following the Chernobyl Nuclear Power Plant disaster.
Int J Phytoremediation
August 2025
Department of Natural Sciences, Merrimack College, North Andover, MA, USA.
The Chernobyl Nuclear Power Plant (CNPP) disaster in 1986 released significant amounts of radiocesium (Cs), radiostrontium (Sr), and radioiodine (I) across Europe and eastern areas of Russia, leading to widespread environmental contamination that negatively impacted human health and harmed flora and fauna in a variety of terrestrial and aquatic ecosystems. The long-term effects of the Chernobyl incident remain a persistent concern, particularly due to radiocesium which has a half-life of 30.17 years, and various environmental and human-driven events that continue to resuspend radionuclides into the environment.
View Article and Find Full Text PDFGene Expression Analysis of Papillary Thyroid Carcinoma With Lymph Node Metastasis and Radioiodine Refractivity.
Cureus
June 2025
UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, MYS.
Background/aim: Papillary thyroid carcinoma (PTC) is the most prevalent form of thyroid cancer (TC) and is generally associated with a favorable prognosis. Nevertheless, aggressive variants of PTC that exhibit metastasis and resistance to radioiodine (RAI) therapy present significant clinical challenges. This study sought to generate a preliminary dataset on gene expression in RAI-refractory PTC using microarray analysis.
View Article and Find Full Text PDFCD66b Tumor-Infiltrating Neutrophil-like Monocytes as Potential Biomarkers for Clinical Decision-Making in Thyroid Cancer.
Medicina (Kaunas)
July 2025
Department of Basic Oncology, Cancer Institute, Hacettepe University, Ankara 06230, Turkey.
: Thyroid nodules are a common endocrine disorder, with 10-15% exhibiting malignancy. Accurate differentiation of malignant and benign nodules is crucial for optimizing treatment outcomes. Current diagnostic tools, such as the Bethesda classification and fine-needle aspiration biopsy (FNAB), are limited in sensitivity and specificity, particularly in indeterminate cases.
View Article and Find Full Text PDF